遗传性等离子素缺乏的基因型-表型相关性:来自18名脑梗塞患者的分子机制
Yifan Lu1, Haixiao Xie1, Dandan Yu1
1Department of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
概括
与PLG基因变异相关的遗传性等离子素缺乏症显著增加了脑梗塞的风险. 这是由于塑原体活性降低,从而影响血液凝块的分解.
科学领域:
- 遗传学 遗传学 是一个
- 血液学 血液学 血液学
- 神经学 神经学
背景情况:
- 遗传性等离子素 (PLG) 缺乏症是一种罕见的先天性疾病,影响纤维素分解.
- 这项研究调查了PLG基因变异与遗传性血栓性疾病,特别是脑梗塞 (CI) 之间的联系.
研究的目的:
- 在18名遗传性PLG缺乏症患者中分析PLG基因变异.
- 调查与这些PLG基因变异相关的临床表现.
主要方法:
- 对18名CI和PLG活性降低的患者进行了回顾性研究 (PLG:A).
- 使用聚合酶链反应 (PCR) 和直接测序对PLG基因变异的分析.
- 凝血指标的测量,包括PLG活性 (PLG:A) 和PLG抗原 (PLG:Ag).
主要成果:
- 所有18名患者在MRI上都显示了最近的脑梗塞病变.
- PLG:A水平在19%至67%之间,所有患者都被诊断出患有缺血性质.
- 鉴定了四种类型的PLG基因变异:c.1858G > A (p.Ala620Thr),c.398A > G ((p.His133Arg),c.2108G > A ((p.Gly703Asp) 和c.1702G > A (p.Gly568Arg).这些变异包括:c.1858G > A (p.Ala620Thr),c.398A > G ((p.His133Arg),c.2108G > A ((p.Gly703Asp),以及c.1702G > A (p.Gly568Arg). 最常见的是p.Ala620Thr突变;p.His133Arg和p.Gly568Arg是新的.
结论:
- 导致遗传性PLG缺陷的PLG基因变异增加了脑梗塞的风险.
- 下降的PLG催化活性和受损的纤维素分解可能是导致这种风险增加的机制.
相关概念视频
01:09Cytoskeletal Linker Proteins - Plakins
2.0K
Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
2.0K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
159
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159
01:29Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
01:15Ischemic Stroke ll: Pathophysiology
54
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
54
01:29Hemorrhagic Stroke ll: Pathophysiology
30
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
30